Cat. No JK1024721_50_MG
J&K Chemical

Product Information

Product Name
Telaprevir, 98%, Hepatitis c virus (HCV)NS3-4Aserine protease inhibitors
Brand Name
J&K
Product Number
1024721
CAS
402957-28-2
SDS Document
Certificate of Analysis (COA)​
COA not found

General Information

PubChem CID
3010818
IUPAC Name
(3S,3aS,6aR)-2-(2S)-2-(2S)-2-cyclohexyl-2-(pyrazine-2-carbonylamino)acetylamino-3,3-dimethylbutanoyl-N-(3S)-1-(cyclopropylamino)-1,2-dioxohexan-3-yl-3,3a,4,5,6,6a-hexahydro-1H-cyclopentacpyrrole-3-carboxamide
InChI Key
BBAWEDCPNXPBQM-GDEBMMAJSA-N
SMILES
CCCC@@H(C(=O)C(=O)NC1CC1)NC(=O)C@@H2C@H3CCCC@H3CN2C(=O)C@H(C(C)(C)C)NC(=O)C@H(C4CCCCC4)NC(=O)C5=NC=CN=C5

Safety Information

Storage Condition
Freezer -20℃

References Data Source From Pubchem

Reengineering Protease Inhibitors to Disrupt Hsp70 Chaperone Function

Publication Name: Angewandte Chemie (International ed. in English)
Publication Date: 2026-05-19
DOI: 10.1002/anie.1777033

Drug-related suicide AEs and depression vary between sexes

Publication Name: Reactions Weekly
Publication Date: 2026-02-28
DOI: 10.1007/s40278-026-92737-3

Antiviral drug discovery and development: challenges and future directions

Publication Name: Signal Transduction and Targeted Therapy
Publication Date: 2026-02-25
DOI: 10.1038/s41392-025-02539-7

Investigating the time-dependent withdrawal effects of sofosbuvir and/or ribavirin on male mice: a histological and histophotometrical approach

Publication Name: Naunyn-Schmiedeberg's Archives of Pharmacology
Publication Date: 2026-02-03
DOI: 10.1007/s00210-026-04974-x

Direct-acting antivirals for chronic hepatitis C infection: a protocol for a systematic review of observational studies

Publication Name: Systematic Reviews
Publication Date: 2026-01-31
DOI: 10.1186/s13643-026-03078-0

Telaprevir, 98%, Hepatitis c virus (HCV)NS3-4Aserine protease inhibitors

Just added to your wishlist:
My Wishlist
You've just added this product to the cart:
Go to cart page